The Assessment of Drugs in Obsessional States

Overview

Journal Br J Clin Pharmacol

Specialty Pharmacology

Date 1976 Feb 1

PMID 973952

Citations 1

Authors

R Philpott

Affiliations

Soon will be listed here.

Citing Articles

Intravenous Clomipramine for Treatment-Resistant Obsessive-Compulsive Disorder.

Karameh W, Khani M Int J Neuropsychopharmacol. 2015; 19(2).

PMID: 26221004 PMC: 4772819. DOI: 10.1093/ijnp/pyv084.

References

Kellner R . 2. Improvement criteria in drug trials with neurotic patients. Psychol Med. 1972; 2(1):73-80. DOI: 10.1017/s0033291700045645. View

Marks I, Viswanathan R, Lipsedge M, Gardner R . Enhanced relief of phobias by flooding during waning diazepam effect. Br J Psychiatry. 1972; 121(564):493-505. DOI: 10.1192/bjp.121.5.493. View

Tyrer P, Candy J, Kelly D . Phenelzine in phobic anxiety: a controlled trial. Psychol Med. 1973; 3(1):120-4. DOI: 10.1017/s0033291700046419. View

Collins G . The use of parenteral and oral chlorimipramine (Anafranil) in the treatment of depressive states. Br J Psychiatry. 1973; 122(567):189-90. DOI: 10.1192/bjp.122.2.189. View

Gillan P, Rachman S . An experimental investigation of desensitization in phobic patients. Br J Psychiatry. 1974; 124(0):392-401. DOI: 10.1192/bjp.124.4.392. View

FREED A, Kerr T, Roth M . The treatment of obsessional neurosis. Br J Psychiatry. 1972; 120(558):590-1. DOI: 10.1192/bjp.120.558.590-b. View

Hamilton M . The assessment of anxiety states by rating. Br J Med Psychol. 1959; 32(1):50-5. DOI: 10.1111/j.2044-8341.1959.tb00467.x. View

Hamilton M . A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960; 23:56-62. PMC: 495331. DOI: 10.1136/jnnp.23.1.56. View

Marks I, Gelder M . Transvestism and fetishism: clinical and psychological changes during faradic aversion. Br J Psychiatry. 1967; 113(500):711-29. DOI: 10.1192/bjp.113.500.711. View

10.

Johnston D, Gath D . Arousal levels and attribution effects in diazepam-assisted flooding. Br J Psychiatry. 1973; 123(575):463-6. DOI: 10.1192/bjp.123.4.463. View

11.

Marks I . Research in neurosis: a selective review. 2. Treatment. Psychol Med. 1974; 4(1):89-109. DOI: 10.1017/s0033291700040344. View

12.

Marks I . New approaches to the treatment of obsessive-compulsive disorders. J Nerv Ment Dis. 1973; 156(6):420-6. DOI: 10.1097/00005053-197306000-00007. View

13.

Cooper J, Kelleher M . The Leyton Obsessional Inventory: a principal components analysis on normal subjects. Psychol Med. 1973; 3(2):204-8. DOI: 10.1017/s0033291700048534. View

14.

Capstick N, Seldrup J . Phenomenological aspects of obsessional patients treated with clomipramine. Br J Psychiatry. 1973; 122(571):719-20. DOI: 10.1192/bjp.122.6.719. View

15.

Rachman S, Marks I, Hodgson R . The treatment of obsessive-compulsive neurotics by modelling and flooding in vivo. Behav Res Ther. 1973; 11(4):463-71. DOI: 10.1016/0005-7967(73)90105-8. View

16.

Rachman S . Primary obsessional slowness. Behav Res Ther. 1974; 12(1):9-18. DOI: 10.1016/0005-7967(74)90026-6. View

17.

Van Renynghe de Voxvrie . [Use of anafranil (G 34586) in obsessive neuroses]. Acta Neurol Psychiatr Belg. 1968; 68(10):787-92. View

18.

Marshall W . Treatment of obsessional illnesses and phobic anxiety states with clomipramine. Br J Psychiatry. 1971; 119(551):467-8. DOI: 10.1192/bjp.119.551.467. View

19.

Kelleher M . Cross-national (Anglo-Irish) differences in obsessional symptoms and traits of personality. Psychol Med. 1972; 2(1):33-41. DOI: 10.1017/s003329170004558x. View

20.

Hodgson R, Rachman S, Marks I . The treatment of chronic obsessive-compulsive neurosis: follow-up and further findings. Behav Res Ther. 1972; 10(2):181-9. DOI: 10.1016/s0005-7967(72)80012-3. View